Early Data Indicates an A.I.-Generated Drug Could Slow Aging

Early data from a study published in Nature Aging indicates that an A.I.-generated drug candidate, named TAC-101, could slow aging in mice, extending their lifespan by 10%. The research, led by scientists at Insilico Medicine, used the company's generative A.I. platform to design the molecule, which targets a protein linked to cellular aging.

Article URL: https://www.nytimes.com/2026/09/07/science/ai-generated-drug-longevity.html Comments URL: https://news.ycombinator.com/item?id=49596784 Points: 2 Comments: 0